These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19776738)

  • 1. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
    Nyunt MM; Adam I; Kayentao K; van Dijk J; Thuma P; Mauff K; Little F; Cassam Y; Guirou E; Traore B; Doumbo O; Sullivan D; Smith P; Barnes KI
    Clin Pharmacol Ther; 2010 Feb; 87(2):226-34. PubMed ID: 19776738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
    Parikh S; Rosenthal PJ
    Clin Pharmacol Ther; 2010 Feb; 87(2):160-2. PubMed ID: 20107451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
    Serra-Casas E; Menéndez C; Bardají A; Quintó L; Dobaño C; Sigauque B; Jiménez A; Mandomando I; Chauhan VS; Chitnis CE; Alonso PL; Mayor A
    J Infect Dis; 2010 Jan; 201(1):123-31. PubMed ID: 19954383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
    Green MD; van Eijk AM; van Ter Kuile FO; Ayisi JG; Parise ME; Kager PA; Nahlen BL; Steketee R; Nettey H
    J Infect Dis; 2007 Nov; 196(9):1403-8. PubMed ID: 17922406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.
    Tukur IU; Thacher TD; Sagay AS; Madaki JK
    Am J Trop Med Hyg; 2007 Jun; 76(6):1019-23. PubMed ID: 17556604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
    Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Dorman EK; Kawuondo K; Marsh K; Hviid L
    Infect Immun; 2004 Sep; 72(9):5027-30. PubMed ID: 15321995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent preventive treatment against malaria: an update.
    Gosling RD; Cairns ME; Chico RM; Chandramohan D
    Expert Rev Anti Infect Ther; 2010 May; 8(5):589-606. PubMed ID: 20455687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
    Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
    Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
    J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
    Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
    J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
    Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
    J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
    Tinto H; Ouédraogo JB; Zongo I; van Overmeir C; van Marck E; Guiguemdé TR; D'Alessandro U
    Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.